A judge has ordered Sydney coffee shop chain 85 Degrees to pay a $1.44 million penalty for underpayments by its franchisees, saying it cannot be seen as acceptable for franchisors to “turn a blind eye” to contraventions by franchisees.
The Australian Energy Regulator has secured a $2.75 million penalty in a case against oil and gas company Santos alleging record-keeping failures in breach of the National Gas Rules.
A judge has allowed a coal mine truck driver to bring claims as much as five years out of time against Mt Arthur Coal and Chandler Macleod over alleged bullying by a colleague, finding the delay in bringing the case was justified by a period of disability which left the worker “severely impaired in her capacity to pursue any litigation”.
MinterEllison’s Perth office has welcomed a new energy and resources expert from Dentons, fleshing out the firm’s Western Australian capabilities.
A class action has argued Medibank cannot claim legal professional privilege over three Deloitte reports after disclosing them to reassure the market and customers after a massive 2022 data breach.
Domino’s is facing a potential shareholder class action for allegedly misleading the market about its expected performance in Japan.
The judge overseeing a consumer class action against wealth manager Colonial First State Investments has given the green light to a $100 million settlement, but questioned a $23.1 million cut to funder Augusta under a “strange” funding agreement.
Former radio host Antoinette Lattouf is planning to bring an unfair termination case against the broadcaster, after the Fair Work Commission found the ABC terminated her from a casual presenting role.
Amid allegations of inappropriate behaviour by Nine’s former news director, plaintiff law firm Maurice Blackburn says it is representing “a number of women” in the television industry who are pursuing sexual harassment and discrimination claims.
A judge has upheld Neurim Pharmaceutical’s claim for additional damages against two generic drug companies found to have infringed its patent for insomnia drug Circadin, despite the company’s failure to comply with an earlier ruling.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
